Exploratory Clinical Study of MT-2301

Clinical trial NCT02140047 · COMPLETED

Trial details

NCT number: NCT02140047
Sponsor: Tanabe Pharma Corporation
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Haemophilus Influenza Type b

Start date: 2014-04-01
Primary completion: 2015-01-01
Enrollment: 154

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.